Apryl receives over four million euros in seed funding

Until recently, the start-up was still called Oviavo. Now it is receiving support from angel investors in particular.

Apryl has raised 4.1 million euros in a seed financing round. Breega led the round, with existing investor Atlantic Labs participating again. Crista Galli Ventures, Myelin VC, Alliance For Impact Ventures, Westtech Ventures and various business angels also invested. These include Kate Ryder, Managing Director of Maven Clinic, a virtual women's and family clinic from New York. The founder and CEO of Overture Life Martin Varsavsky has also invested. A total of 66 percent of the business angels invested are women.

"We have been monitoring the global market for fertility services for some time and are convinced that Apryl's platform is the only one capable of meeting the unique and diverse needs of the European market," says Martin Varsavsky of Overture Life, who invested in Apryl. Apryl enables companies across Europe to support their employees with family planning through a benefits program. Services include, for example, counseling, access to fertility clinics, egg and sperm freezing treatments, artificial insemination and adoption. Normally, couples have to cover the costs of fertility treatments and adoption themselves. Through Apryl, companies can contribute to the costs. By treating employees in a family-friendly way, the aim is to retain young talent within the company.

Until recently, Apryl was still called Oviavo. Jenny Saft and Tobias Kaufhold founded the start-up in Berlin at the end of 2019.